Biomarkers and Mechanisms in Knee Osteoarthritis

Knee osteoarthritis is a degenerative joint disorder characterised by progressive cartilage breakdown, subchondral bone remodelling and low-grade synovial inflammation. Molecular biomarkers detectable in synovial fluid, serum or urine have emerged as tools for early diagnosis, disease monitoring and evaluation of therapeutic response. Cartilage oligomeric matrix protein (COMP) and C-telopeptides of type II collagen (CTX-II) reflect matrix turnover, while matrix metalloproteinases (MMPs) and aggrecan fragments indicate enzymatic degradation of cartilage extracellular matrix. Pro-inflammatory cytokines such as interleukin-6 and tumour necrosis factor-α contribute to chondrocyte catabolism and synovial activation. Growing evidence implicates mechanical loading and altered biomechanics in driving molecular changes: abnormal joint loading accelerates collagen cleavage and upregulates degradative enzymes. Concurrently, subchondral bone expresses osteoclastic mediators and vascular endothelial factors, promoting angiogenesis and bone sclerosis that further destabilise the osteochondral unit. Advances in omics technologies and machine learning have begun to integrate gene-expression profiles, signalling pathways (for example Wnt, TGF-β and PI3K-Akt) and immune cell infiltration patterns to uncover key drivers of cartilage degeneration. Clinically, exercise interventions demonstrate transient rises in serum COMP and anti-inflammatory cytokines, highlighting the dynamic interplay between biomechanics and molecular responses. A clearer delineation of normal versus pathological biomarker trajectories promises to refine risk stratification, facilitate early intervention and support the development of structure-modifying therapies.

Research from Nature Portfolio

A recent investigation in elite athletes examined associations between serum cartilage biomarkers and musculoskeletal function, revealing that levels of COMP and aggrecan correlate with peak muscle torque across trunk and knee joints. This study further identified that vitamin D status modulates muscle performance indices linked to cartilage metabolism, suggesting a dual role for vitamin D in musculoskeletal health and joint integrity. These findings underscore the importance of biomechanical–biochemical cross-talk in maintaining cartilage homeostasis and suggest that optimising vitamin D levels may support both muscle function and cartilage resilience in at-risk populations.

Biomarkers and Mechanisms in Knee Osteoarthritis publication trend

The graph below shows the total number of articles in biomarkers and mechanisms in knee osteoarthritis across all publications each year (not limited to Nature Index journals).

Technical terms

Biomarker: A measurable biological molecule that indicates normal or pathological processes or responses to therapy.

Cartilage Oligomeric Matrix Protein (COMP): A non-collagenous protein of the cartilage extracellular matrix released during cartilage turnover.

C-Telopeptide of Type II Collagen (CTX-II): A peptide fragment generated by enzymatic cleavage of type II collagen, reflecting cartilage degradation.

Matrix Metalloproteinases (MMPs): A family of zinc-dependent enzymes that degrade extracellular matrix components, including collagen and aggrecan.

Extracellular Matrix (ECM): The complex network of proteins and proteoglycans that provides structural and biochemical support to cells within cartilage.

Cytokines: Small signalling proteins released by immune and stromal cells that regulate inflammation and tissue remodelling.

References

1. Molecular Assessment of Healthy Pathological Articular Cartilages in Physically Active People: A Scoping Review. International Journal of Molecular Sciences (2023).
2. Association of cartilage metabolism biomarkers and 25(OH)D levels with muscle biomechanical functions in professional rowers and canoeists. Scientific Reports (2024).
3. Identification of diagnostic biomarkers for osteoarthritis through bioinformatics and machine learning. Heliyon (2024).
4. Combined detection of serum CTX-II and COMP concentrations in osteoarthritis model rabbits: an effective technique for early diagnosis and estimation of disease severity. Journal of Orthopaedic Surgery and Research (2016).
5. The time course and mechanisms of change in biomarkers of joint metabolism in response to acute exercise and chronic training in physiologic and pathological conditions. European Journal of Applied Physiology (2019).
6. Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. BMC Musculoskeletal Disorders (2011).
7. Relationships amongst osteoarthritis biomarkers, dynamic knee joint load, and exercise: results from a randomized controlled pilot study. BMC Musculoskeletal Disorders (2013).